Open Access(PI3K)/AKT signalling pathway – a Pandora’s box in oral squamous cell carcinoma
Author(s) -
Alexandra Totan,
Daniela Miricescu,
Iulia-Ioana Stănescu-Spînu,
Andreea Cristiana Didilescu,
Marina Imre-Melescanu,
Ana Maria Cristina Țâncu,
Cosmin Totan,
Tudor Spinu,
Maria Greabu
Publication year - 2019
Publication title -
romanian journal of medical practice
Language(s) - English
Resource type - Journals
eISSN - 2069-6108
pISSN - 1842-8258
DOI - 10.37897/rjmp.2019.4.8
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cancer research , hedgehog signaling pathway , signalling pathways , cancer , biology , head and neck squamous cell carcinoma , basal cell , signal transduction , medicine , bioinformatics , head and neck cancer , microbiology and biotechnology
Molecular mechanisms of cancer involve mutations of several genes triggering various pathway alterations. Oral squamous cell carcinoma (OSCC) represents approximately 10% of the head and neck cancers and is one of the leading causes of morbidity and mortality in Central and Eastern Europe. The main aim of this review article is to present an overview of one of the major actors in cellular processes’ regulation that are key features of cancer molecular events the PI3K/AKT signalling pathway. The altered molecular signalling pathways in OSCC have been discussed, emphasizing the frequent disruption of the PI3K/AKT pathway in cancer. Thus, the aspects presented in this article highlight this pathway as an important target for new therapeutic strategies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom